Talaris Therapeutics Wins 2019 “Big Idea” Xconomy Award by Seini Moimoi | Sep 18, 2019 | Portfolio News
Poseida Therapeutics Receives US FDA Orphan Drug Designation For P-BCMA-101 for the Treatment of Multiple Myeloma by Seini Moimoi | Sep 13, 2019 | Portfolio News
FDA Allergenic Products Advisory Committee Votes to Support the Use of Aimmune’s PALFORZIA™ (AR101) for Peanut Allergy by Seini Moimoi | Sep 13, 2019 | Portfolio News
Molecular Templates, Inc. Reports Second Quarter 2019 Financial Results by Seini Moimoi | Sep 12, 2019 | Portfolio News
